Updates From Elizabeth Holmes’ Trial
Scathing testimonies from former Theranos lab director, whistleblower Erika Cheung and more
--
Elizabeth Holmes, former founder and CEO of the now-defunct blood-testing company Theranos, is currently on trial and facing charges of defrauding patients and investors. A few weeks ago I gave a quick recap on the history of Holmes and Theranos, and why she’s currently on trial for fraud.
It’s now been about a month since Holmes first entered the courtroom. With a proposed witness list of 280 people this case will take a while, but it’s already proving to be a captivating ride.
John Carreyrou, Wall Street Journal investigative journalist and author of “Bad Blood: Secrets and Lies in a Silicon Valley Startup,” has been giving play-by-play coverage of the trial in his podcast, “Bad Blood: The Final Chapter.” (Seriously, go listen. No one covers this drama better than Carreyrou.)
Holmes’ team added him to their proposed witness list in what some believe is a ruse to keep Carreyrou out of the courtroom and from reporting firsthand on the high-profile case alongside other media. Carreyrou’s attorneys asked the court to consider his First Amendment rights and for clarity on what testimony may be sought if he’s called as a witness.
Carreyrou’s motion to the court pointed out that Holmes's defense team only added him to its witness list after he made public his plans to cover the trial with a podcast. On Oct. 14, Judge Cousins granted Carreyrou’s motion and he was allowed back in the courtroom.
Whistleblower testified about ignored concerns and manipulated test results
In mid-September, Theranos whistleblower Erika Cheung took the witness stand for the prosecution to testify that her Theranos bosses ignored her concerns about a high rate of failed quality control test results. Cheung worked as a lab associate in Theranos’ research lab and in its clinical…
